Risk of suicidal ideation with weight-loss drugs being investigated by European regulators
European Medicines Agency reviewing semaglutide and liraglutide after reports of links to suicidal thoughts and self-harm.
The European Medicines Agency is looking into concerns that weight-loss drugs like semaglutide and liraglutide may be linked to suicidal ideation and potential self-harm.
Three case reports from Iceland spurred the agency’s safety committee to conduct a medication review, CNN reported Monday.
The Icelandic Medicines Agency reported two cases of suicidal thoughts.
One happened after use of semaglutide (Ozempic and Wegovy) and the other after taking liraglutide (Saxenda).
